NEOMERO1 Clinical Trial Status

The core strategy of the NEOMERO Project includes the combination of two clinical trials: Neomero1 (an open-label, randomised, multicenter, comparator-controlled study to evaluate the PK, efficacy and safety of meropenem as compared with standard antibiotic therapy in neonates and infants aged < 3 months treated in neonatal intensive care units (NICU) for late onset sepsis [...]